05Mar 2023
New mRNA-Based Vaccine for Omicron COVID-19 Strain Proves Effective in Animal Models

New mRNA-Based Vaccine for Omicron COVID-19 Strain Proves Effective in Animal Models

The article reports preclinical data for a new COVID-19 vaccine called CV0501, which encodes the spike protein of the Omicron BA.1 variant of SARS-CoV-2. The study found that both monovalent CV0501 and bivalent CV0501/ancestral N1mΨ immunization induced robust neutralizing antibody titers against several Omicron subvariants and other SARS-CoV-2 variants in animal models. Monovalent CV0501 was found to significantly reduce SARS-CoV-2 BA.2 viral loads in the airways of hamsters, demonstrating its protective efficacy. The vaccine has now advanced into Phase 1 clinical trials in humans.

  • #family health

Like

Save

Share